Ocular melanoma: Epidemiology, clinical presentation and relationship with dysplastic nevi

Ophthalmologica

Volumn 218, Issue 2, 2004, Pages 111-114

  Richtig, E ^a   Langmann, G ^a   Mullner K ^a   Smolle, J ^a  

^a UNIVERSITY HOSPITAL GRAZ   (Austria)

Author keywords

Cutaneous melanoma; Dysplastic nevi; Ocular melanoma, epidemiology

Indexed keywords

ADULT; AGED; ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CANCER PATIENT; CANCER RISK; CHOROID MELANOMA; CILIARY BODY MELANOMA; CLINICAL FEATURE; CONJUNCTIVA; CONJUNCTIVAL MELANOMA; CONTROLLED STUDY; DISEASE ASSOCIATION; DYSPLASTIC NEVUS; EYE CANCER; FAMILY HISTORY; FEMALE; GEOGRAPHY; HUMAN; IRIS MELANOMA; LACRIMAL SAC; LACRIMAL SAC MELANOMA; MAJOR CLINICAL STUDY; MALE; MELANOMA; SKIN CARCINOMA; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; UNIVERSITY HOSPITAL; UVEA MELANOMA;

ADULT; AGE DISTRIBUTION; AGED; AGED, 80 AND OVER; AUSTRIA; DYSPLASTIC NEVUS SYNDROME; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; RISK FACTORS; SKIN NEOPLASMS; UVEAL NEOPLASMS;

EID: 1542617834     PISSN: 00303755     EISSN: None     Source Type: Journal    
DOI: 10.1159/000076146     Document Type: Article

References (33)

1. Graham BJ, Duane TD: Ocular melanoma task force report. Am J Ophthalmol 1980;90:728-733.
2. Egan KM, Seddon JM, Glynn R, Gragoudas ES, Albert DM: Epidemiologic aspects of uveal melanoma. Surv Ophthalmol 1988;32:239-251.
3. Bornfeld N: Diagnose und Therapie maligner Melanome der Uvea (Aderhaut und Ziliarkörper). Ophthalmologe 1992;89:W61-W78.
4. Mooy CM, De Jong PTVM: Prognostic parameters in uveal melanoma: A review. Surv Ophthalmol 1996;41:215-228.
5. Aaberg TM Jr: Current clinical management options for uveal melanoma. Ophthalmol Clin North Am 1999;12:177-182.
6. Schmidt M, Hölzel D: Klinisch-epidemiologische Daten zum malignen Melanom aus dem Bereich des Tumorzentrums München; in Volkenandt M, Plewig G (eds): Maligne Melanome. Empfehlungen zur Diagnostik, Therapie und Nachsorge, ed 5. München, Zuckschwerdt, 2000, pp 2-6.
7. Garbe C, McLeod GRC, Büttner PG: Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer 2000;89:1269-1278.
8. Diepgen TL, Mahler V: The epidemiology of skin cancer. Br J Dermatol 2002;146(suppl 61):1-6.
9. Garbe C, Blum A: Epidemiology of cutaneous melanoma in Germany and worldwide. Skin Pharmacol Appl Skin Physiol 2001;14:280-290.
10. Jones WO, Harman CR, Ng AKT, Shaw JH: Incidence of malignant melanoma in Auckland, New Zealand: Highest rates in the world. World J Surg 1999;23:732-735.
11. Seddon JM, Egan K: Application of epidemiological methods to the study of eye disease: Uveal melanoma; in Albert DM, Jakobiec FA (eds): Principles and Practice of Ophthalmology. Basic Sciences. Philadelphia, Saunders, 1993, pp 1245-1249.
12. Jäckel A, Bock M, Deichmann M, Waldmann V, Näher H: Therapie des metastasierten malignen Uveamelanoms. Hautarzt 2001;52:98-103.
13. Cutler SJ, Young JL, Connelly RR: Third national cancer survey: Incidence data. Natl Cancer Inst Monogr 1975;41:1-454.
14. Wöll E, Bedikian A, Legha SS: Uveal melanoma: Natural history and treatment options for metastatic disease. Melanoma Res 1999;9:575-581.
15. Gragoudas ES, Egan KM, Seddon JM, Glynn RJ, Walsh SM, Finn SM, Munzenrider JE, Spar MD: Survival of patients with metastases from uveal melanoma. Ophthalmology 1991;98:383-389.
16. Garbe C, Büttner P, Weiss J, Soyer HP, Stocker U, Krüger S, Roser M, Weckbecker J, Panizzon R, Bahmer F, Tilgen W, Guggenmoos-Holzmann I, Orfanos C: Associated factors in the prevalence of more than 50 common melanocytic nevi, atypical melanocytic nevi, and actinic lentigines: Multicenter case-control study of the Central Malignant Melanoma Registry of the German Dermatological Society. J Invest Dermatol 1994;102:700-705.
17. Santigli E: Demographie: Die steirische Wohnbevölkerung; in Santigli E, Adamer-König E, Mitter B, Piribauer F (eds): Gesundheitsbericht 2000 für die Steiermark. Graz, Medienfabrik, Steiermärkische Landesdruckerei, 2000, p 28.
18. Garbe C: Melanozytäre Nävi und Melanomrisiko: Leitlinien für die Betreuung und Therapie; in Garbe C, Dummer R, Kaufmann R, Tilgen W (eds): Dermatologische Onkologie. Berlin, Springer, 1997, pp 215-230.
19. Volkenandt M, Schmidt M, Konz B, Gummer M, Hein R, Plewig G, Hölzel D: Klinisch-epidemiologische Daten von Patienten mit malignen Melanomen aus dem Bereich des Tumorzentrums München 1977 bis 1997. Hautarzt 1999;50:470-478.
20. Günalp I, Batioglu F: Effect of pre-enucleation irradiation on the survival of patients with uveal melanoma. Ophthalmologica 1998;212:231-235.
21. Char DH, Kroll S, Phillips TL: Uveal melanoma: Growth rate and prognosis. Arch Ophthalmol 1997;115:1014-1018.
22. Damato B: The management of uveal melanoma in the next millennium. Ophthalmol Clin North Am 1999;12:493-506.
23. Ah-Fat FG, Damato BE: Delays in diagnosis of uveal melanoma and effect on treatment. Eye 1998;12:781-782.
24. Holden R, Damato BE: Preventable delays in the treatment of intraocular melanoma in the UK. Eye 1996;10:127-129.
25. Char DH, Kroll SM, Miller T, Castro J, Quivey J: Irradiated uveal melanomas: Cytopathologic correlation with prognosis. Am J Ophthalmol 1996;122:509-513.
26. Schwartz LH, Ferrand R, Boelle PY, Maylin C, D'Hermies F, Virmont J: Lack of correlation between the location of choroidal melanoma and ultraviolet-radiation dose distribution. Radiat Res 1997;147:451-456.
27. Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK: Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res 1990;50:5773-5777.
28. Garbe C: Sonne und malignes Melanom. Hautarzt 1992;43:251-257.
29. Paton D, Thomas LB: Simultaneous occurrence of primary malignant melanomas of the eye and the skin. Arch Ophthalmol 1959;62:645-652.
30. Lynch HT, Fusaro RM, Pester J, Oosterhuis JA, Went LN, Rumke P, Neering H, Lynch JF: Tumour spectrum in the FAMMM syndrome. Br J Cancer 1981;44:553-560.
31. Greene MH, Sanders RJ, Chu FC, Clark WH Jr, Elder DE, Cogan DG: The familial occurrence of cutaneous melanoma, intraocular melanoma, and the dysplastic nevus syndrome. Am J Ophthalmol 1983;96:238-245.
32. Vink J, Crijns MB, Mooy CM, Bergman W, Oosterhuis JA, Went LN: Ocular melanoma in families with dysplastic nevus syndrome. J Am Acad Dermatol 1990;23:858-862.
33. Hammer H, Olah J, Toth-Molnar E: Dysplastic nevi are a risk factor for uveal melanoma. Eur J Ophthalmol 1996;6:472-474.